Trials / Completed
CompletedNCT00794976
Dexamethasone Iontophoretic Patch for the Treatment of Pain Associated With Lateral Epicondylitis
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of a Dexamethasone Iontophoretic Transdermal Patch for the Treatment of Pain Associated With Lateral Epicondylitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 216 (actual)
- Sponsor
- Travanti Pharma Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to determine the safety and efficacy of a dexamethasone iontophoretic transdermal patch for the treatment of pain associated with lateral epicondylitis (tennis elbow).
Detailed description
Detailed Description: This trial is a randomized, double-blind, placebo-controlled, parallel-group trial in subjects diagnosed with lateral epicondylitis (tennis elbow). Subjects entered into the trial will be assigned to one of four treatment groups. The total duration is up to 13 days of trial participation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone Iontophoretic Patch (low dose) | |
| DRUG | Dexamethasone Iontophoretic Patch (high dose) | |
| DRUG | Dexamethasone Passive Patch | |
| DRUG | Placebo Patch |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2009-05-01
- Completion
- 2009-05-01
- First posted
- 2008-11-21
- Last updated
- 2015-05-13
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00794976. Inclusion in this directory is not an endorsement.